Switching From Wegovy To Mounjaro UK - Complete Guide

Clinically Proven UK Registered Pharmacy

Cheapest Switching From Wegovy To Mounjaro UK - £124.99

Switch to Mounjaro at the cheapest UK price from £124.99 with expert guidance and £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Complete Guide to Switching From Wegovy to Mounjaro in the UK

Switching from Wegovy to Mounjaro UK is becoming increasingly common as patients explore tirzepatide's dual-action mechanism for enhanced weight management. Many UK patients transitioning between these GLP-1 treatments seek clarity on safe dosing protocols, expected timelines, and regulatory requirements. This comprehensive guide provides expert pharmacist-verified protocols for switching from Wegovy to Mounjaro, supported by clinical trial data and UK prescriber guidelines.

Why Patients Consider Switching From Wegovy to Mounjaro UK

The decision to switch from Wegovy to Mounjaro UK typically stems from several clinical considerations. Mounjaro (tirzepatide) offers a dual-action mechanism, activating both GIP and GLP-1 receptors, whilst Wegovy (semaglutide) targets GLP-1 receptors alone. In the SURPASS-2 trial, tirzepatide demonstrated superior weight reduction compared to semaglutide, with patients losing an average of 12.4kg on the 15mg dose versus 6.2kg on semaglutide 1mg over 40 weeks [1].

Some UK patients experience plateaued weight loss on Wegovy after several months of treatment, prompting exploration of alternative therapies. Others may find Mounjaro's dosing schedule or side effect profile better suited to their individual physiology. Cost considerations also influence treatment decisions, though both medications require clinical assessment by a UK-registered prescriber before dispensing. At Cured Pharmacy, Mounjaro is available from £124.99 following approval by our clinical team, with transparent pricing displayed before your consultation begins.

Clinical Evidence Supporting the Switch

The SURPASS clinical trial programme provides robust evidence for tirzepatide's efficacy in weight management. SURPASS-3 demonstrated that participants achieved up to 15.7% body weight reduction on the 15mg dose over 72 weeks [2]. When switching from Wegovy to Mounjaro UK, patients often seek these enhanced outcomes, particularly if initial semaglutide response has diminished. However, individual results vary considerably, and no medication guarantees specific weight loss percentages. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), emphasises that treatment selection must align with your medical history, current health status, and prescriber assessment.

Safe Protocol for Switching From Wegovy to Mounjaro UK

The recommended protocol for switching from Wegovy to Mounjaro UK depends on your current Wegovy dose and treatment duration. Most UK prescribers advise completing your final Wegovy injection, then initiating Mounjaro at the 2.5mg starting dose after a 7-day washout period. This approach minimises overlapping GLP-1 receptor activation whilst maintaining therapeutic continuity. Some clinicians may recommend a shorter or longer interval based on individual tolerance and side effect history [3].

If you're currently on Wegovy 2.4mg (the maximum maintenance dose), transitioning to Mounjaro 2.5mg may initially feel like a step down in potency. However, tirzepatide's dual-receptor mechanism often produces comparable or superior glycaemic control and weight reduction at lower nominal doses. The standard Mounjaro escalation schedule increases by 2.5mg increments every 4 weeks, progressing through 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as tolerated. Your UK prescriber will determine the optimal titration speed based on your response and any adverse effects experienced during the switch.

Expected Outcomes When Switching From Wegovy to Mounjaro UK

Patients switching from Wegovy to Mounjaro UK commonly report renewed weight loss momentum within 8-12 weeks of reaching their therapeutic tirzepatide dose. Clinical data suggests that individuals who plateau on GLP-1 monotherapy may experience additional weight reduction when transitioning to dual GIP/GLP-1 agonism, though this is not universal [4]. Appetite suppression patterns may shift slightly, with some patients noting reduced food cravings or altered satiety signals during the initial transition weeks.

Gastrointestinal side effects represent the most frequent concern when switching from Wegovy to Mounjaro UK. Nausea, diarrhoea, and constipation occur in approximately 20-30% of tirzepatide users, typically during dose escalation phases. If you tolerated Wegovy well, you may experience milder side effects with Mounjaro due to prior GLP-1 exposure, though individual responses vary. Staying well-hydrated, eating smaller meals, and avoiding high-fat foods can help minimise digestive discomfort. Any severe or persistent symptoms warrant immediate consultation with your prescriber.

Monitoring Progress After the Switch

UK prescribers typically recommend follow-up assessments at 4-week intervals during the first 16 weeks after switching from Wegovy to Mounjaro UK. These consultations monitor weight trajectory, side effect tolerance, and overall treatment adherence. Blood glucose levels (if you have type 2 diabetes), blood pressure, and lipid profiles may be checked periodically to assess metabolic improvements. At Cured Pharmacy, our clinical team provides ongoing support throughout your treatment journey, ensuring safe and effective medication use under proper medical supervision.

Treatment Active Ingredient Frequency Starting Price
Mounjaro Tirzepatide Weekly injection from £145.00
Wegovy Injection Semaglutide Weekly injection from £89.00
Wegovy Oral Tablets Semaglutide Daily tablet from £83.00
Saxenda Liraglutide Daily injection from £68.00
Mysimba Naltrexone/Bupropion Twice daily tablet from £125.95
Orlistat Orlistat Three times daily from £32.00

Managing Side Effects During the Transition From Wegovy to Mounjaro UK

The side effect profile when switching from Wegovy to Mounjaro UK shares considerable overlap with standalone semaglutide therapy, though the dual-receptor mechanism may produce distinct experiences. Nausea remains the most commonly reported adverse effect, affecting roughly one in four patients during initial tirzepatide doses. This typically resolves within 2-3 weeks as your body adapts to the medication. Eating slowly, choosing bland foods, and avoiding lying down immediately after meals can provide symptomatic relief [5].

Constipation affects approximately 15-20% of Mounjaro users and may be more pronounced during the switch if you experienced similar issues on Wegovy. Increasing dietary fibre intake, maintaining adequate hydration (at least 2 litres of water daily), and regular physical activity support normal bowel function. If constipation persists beyond one week or causes significant discomfort, consult your prescriber before using over-the-counter laxatives. Rare but serious side effects include pancreatitis, gallbladder problems, and severe allergic reactions—seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or difficulty breathing.

Cost Comparison: Switching From Wegovy to Mounjaro UK Pricing

Understanding the financial implications of switching from Wegovy to Mounjaro UK helps patients make informed treatment decisions. At Cured Pharmacy, Mounjaro is available from £124.99 per month following clinical approval, with transparent pricing displayed before your consultation. We offer competitive UK pricing with no hidden fees, and first-time customers receive £20 off using code Weightlossnew. Both medications require ongoing monthly prescriptions, so budgeting for long-term treatment is essential for sustained weight management success.

The comparison table below illustrates pricing across major weight loss treatments available through Cured Pharmacy. While Mounjaro represents a premium option due to its dual-action mechanism, many patients find the enhanced efficacy justifies the investment when switching from Wegovy to Mounjaro UK. All prices include UK prescriber assessment, discreet packaging, and next-day delivery options. Remember that the cheapest option is not always the most clinically appropriate—your treatment choice should be guided by medical suitability, prescriber recommendation, and individual response rather than cost alone.

Long-Term Financial Planning

Weight management medications typically require 12-24 months of continuous use to achieve and maintain significant results. When switching from Wegovy to Mounjaro UK, factor in the cumulative annual cost and whether your budget accommodates sustained treatment. Some patients alternate between medications based on supply availability or financial circumstances, though this approach should only be undertaken under prescriber guidance. Cured Pharmacy's transparent upfront pricing—with costs displayed before consultation—enables informed financial planning without unexpected charges appearing at checkout.

How to Switch From Wegovy to Mounjaro UK Through Cured Pharmacy

The process of switching from Wegovy to Mounjaro UK through Cured Pharmacy begins with our 3-minute online clinical assessment. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and previous Wegovy treatment details. You'll be asked about your current dose, treatment duration, any side effects experienced, and reasons for considering the switch. This information helps our clinical team determine whether Mounjaro is medically appropriate and safe for you [6].

Once approved, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy (registration number 9012511) and dispatched in 100% discreet packaging. Most UK addresses receive next-day delivery when orders are placed before our daily cut-off time. Your first shipment includes the 2.5mg starting dose along with comprehensive patient information leaflets and injection technique guidance. Subsequent prescriptions are managed through your online account, with automatic reminders ensuring you never run out of medication. Our pharmacist-led support team remains available throughout your treatment journey to answer questions about switching from Wegovy to Mounjaro UK or managing any concerns that arise.

Ongoing Clinical Support

Cured Pharmacy provides continuous access to UK-registered healthcare professionals throughout your Mounjaro treatment. If you experience unexpected side effects, have questions about dose escalation, or need guidance on managing the transition from Wegovy, our clinical team is available via phone (+44 116 4646009) or secure messaging. Regular follow-up assessments ensure your treatment remains safe and effective, with dose adjustments made as clinically indicated. This level of ongoing support distinguishes comprehensive pharmacy care from simple medication dispensing, particularly important when switching from Wegovy to Mounjaro UK under medical supervision.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 64-77. [accessed 15 August 2026]
  2. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. [accessed 15 August 2026]
  3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  5. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes–state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 15 August 2026]
  6. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long should I wait when switching from Wegovy to Mounjaro UK?
Most UK prescribers recommend a 7-day washout period after your final Wegovy injection before starting Mounjaro 2.5mg. This interval minimises overlapping GLP-1 activity whilst maintaining treatment continuity, though your prescriber may adjust this based on individual factors.
Will I gain weight during the transition from Wegovy to Mounjaro?
Most patients maintain stable weight or continue gradual loss during the switching from Wegovy to Mounjaro UK transition, particularly if the washout period is kept to 7 days. Any temporary fluctuations typically resolve once you reach therapeutic Mounjaro doses after 8-12 weeks of escalation.
Can I switch directly from Wegovy 2.4mg to a higher Mounjaro dose?
No—UK prescribing guidelines require all patients to start Mounjaro at 2.5mg regardless of previous semaglutide dose when switching from Wegovy to Mounjaro UK. The standard 4-week escalation schedule minimises side effects and allows proper tolerance assessment at each dose level.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials suggest tirzepatide produces greater average weight reduction than semaglutide, with SURPASS-2 showing 12.4kg loss on Mounjaro 15mg versus 6.2kg on Wegovy 1mg over 40 weeks. However, individual responses vary considerably, and some patients achieve excellent results on either medication.
What side effects should I expect when switching from Wegovy to Mounjaro UK?
Nausea, diarrhoea, and constipation are the most common side effects, affecting 20-30% of patients during dose escalation. If you tolerated Wegovy well, you may experience milder symptoms with Mounjaro due to prior GLP-1 exposure, though this varies individually.
Do I need a new prescription when switching from Wegovy to Mounjaro?
Yes—switching from Wegovy to Mounjaro UK requires a new prescription from a UK-registered prescriber. At Cured Pharmacy, our clinical team conducts a fresh assessment to ensure Mounjaro is medically appropriate and safe based on your current health status and treatment history.
How much does it cost to switch from Wegovy to Mounjaro at Cured Pharmacy?
Mounjaro is available from £124.99 per month following clinical approval, with first-time customers receiving £20 off using code Weightlossnew. This includes UK prescriber assessment, genuine licensed medication, and discreet next-day delivery to most UK addresses.
Can I switch back to Wegovy if Mounjaro doesn't suit me?
Yes—patients can return to Wegovy if Mounjaro proves unsuitable, though this requires prescriber approval and a new clinical assessment. When switching from Wegovy to Mounjaro UK initially, allow at least 12-16 weeks to reach therapeutic doses before evaluating effectiveness, as early dose levels may not reflect full treatment potential.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.